XRAY 8-K
DENTSPLY SIRONA Inc. (XRAY)
8-K
2024-08-20
For: 2024-08-15
View Original
Added on
April 11, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation or organization) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||||||||
(Address of Principal Executive Offices) | (Zip Code) | |||||||||||||
(844) 848-0137
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On August 15, 2024, Glenn G. Coleman informed DENTSPLY SIRONA Inc. (the “Company”) of his decision to resign as Executive Vice President, Chief Financial Officer and principal accounting officer of the Company effective November 7, 2024, to pursue another opportunity. Mr. Coleman’s resignation was not because of any disagreement with the Company on any matter relating to the Company’s financial statements, internal controls, operations, policies, or practices, including accounting principles and practices. The Company has begun conducting a formal search for his replacement.
Item 7.01 Regulation FD Disclosure
A copy of the press release announcing the departure of Mr. Coleman is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
The information furnished pursuant to Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.
Item 9.01. Financial Statements and Exhibits
| (d) Exhibits: | ||||||||
| DENTSPLY SIRONA Inc. Press Release issued August 20, 2024 | ||||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL Document) | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
DENTSPLY SIRONA Inc.
| By: | /s/ Richard C. Rosenzweig | |||||||
| Richard C. Rosenzweig | ||||||||
| Executive Vice President, Corporate Development, | ||||||||
| General Counsel and Secretary | ||||||||
Date: August 20, 2024
Dentsply Sirona Initiates Search for New CFO Glenn Coleman to Resign in November to Join Another Company Charlotte, N.C., August 20, 2024 - DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that Executive Vice President and Chief Financial Officer Glenn Coleman will resign effective November 7, 2024, to assume an executive position at another public company. The Company has initiated a search process to identify its next CFO with the assistance of a leading executive search firm. “On behalf of the entire Dentsply Sirona team, I want to extend our deepest gratitude to Glenn for his leadership and many contributions to our Company over the last two years,” said Simon Campion, President and Chief Executive Officer. “During his tenure, Glenn has been instrumental in implementing our business transformation plan, initiating our ERP modernization efforts and advocating for our Employee Resource Groups. I look forward to continuing to work closely with him as we prepare for an orderly transition of his responsibilities in the coming months.” “While I am excited about this next phase of my career, it has been an absolute privilege to be part of the Dentsply Sirona leadership team, and I am entering this new chapter incredibly proud of what we have accomplished,” said Mr. Coleman. “I am confident that Dentsply Sirona is well positioned for success with a strong, aligned leadership team in place to see the Company through its transformation journey.” About Dentsply Sirona Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solution offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters is located in Charlotte, North Carolina. The Company’s shares are listed in the United States on Nasdaq under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products. Contact Information: Investors: Andrea Daley Vice President, Investor Relations +1-704-591-8631 [email protected]
Press: Marion Par-Weixlberger Vice President, Public Relations & Corporate Communications +43 676 848414588 [email protected]